Press releases
- Press releases
- Browse
Press releases
LAB International Inc. today announced that it has entered into an agreement to purchase Focus Inhalation Oy of Turku, Finland. Principal vendors commit to co-invest EUR 4 million in Focus Inhalation. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Aug 2011 - 78 pages - $3,500
Jul 2011 - 131 pages - $3,500
Jan 2011 - 22 pages - $500
Sep 2010 - 27 pages - $2,000
May 2011 - 15 pages - $250
Mar 2011 - 28 pages - $500
Nov 2010 - 178 pages - $1,495
Sep 2009 - 394 pages - $4,000
Jun 2009 - $15,200
Jun 2010 - 210 pages - $2,500
Your selection
Browse By
- Therapeutic target
- Adult respiratory distress syndrome
- Allergy, respiratory
- Asthma
- Asthma, bronchospasm
- Bronchitis
- Chest disorder (other)
- Chlamydia pneumoniae
- Chronic obstructive pulmonary disease
- Cough
- Cystic fibrosis
- Dysplasia, bronchopulmonary
- Emphysema
- Granulomatous lung disease sarcoidosis
- Idiopathic respiratory distress syndrome
- Meconium aspiration syndrome
- Nasal disorder (other)
- Obstructive airway disease
- Pneumonia
- Pneumonocystis carinii lung infection
- Pseudomonas lung infection
- Respiratory disorder (other)
- Respiratory syncytial virus
- Respiratory tract infections
- Rhinitis
- Rhinovirus (common cold)
- Sinusitis
- Sleep apnea
- Throat disorder (other)
- Tuberculosis
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us